Studio Director at Boomerang Ventures
Check size: Boomerang Ventures does not publish a standard current check-size range on its official site.
Dick Aderman is listed in a Studio Director capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Explain the care problem, patient benefit, technical and regulatory plan, commercial evidence and where Boomerang's studio or fund support creates leverage.
Health innovations with strong patient impact, early commercial promise and a credible path through product, regulatory and market risks.
Companies outside connected health or without a plausible commercialization path appear less aligned with the studio-and-fund model.